VERBESSERTE PEPTIDARZNEIMITTEL

European patent · EP3444281 · In force

Register entry

Publication number
EP3444281
Application number
EP18183208
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 20, 2013
Published
Feb 20, 2019
Granted
Nov 3, 2021
Protection ends at the latest
Nov 19, 2033
Next annual fee due
Nov 30, 2026
IPC classes
C07K 19/00 (2006.01)
C07K 7/06 (2006.01)
A61K 38/08 (2019.01)
C07K 1/107 (2006.01)
A61K 38/00 (2006.01)
A61K 38/07 (2006.01)
A61K 38/26 (2006.01)
A61K 38/29 (2006.01)
C09D 101/28 (2006.01)
C07K 5/065 (2006.01)
Priority
US 201261728667 P 20.11.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. Dec 6, 2022

    Change

    Published in Swissreg on 06.12.2022

  5. Sep 14, 2022

    Change

    Published in Swissreg on 14.09.2022

  6. Nov 3, 2021

    Granted

    Published in Swissreg on 03.11.2021

Parties

Holder

Eumederis Pharmaceuticals, Inc.

12707 High Bluff Drive, Suite 200, San Diego, CA 92130, US

Inventor

NESTOR, John, J

Sugar Land, TX 77479, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.